The molecular genetics of hypertrophic cardiomyopathy: Prognostic implications

Europace

Volumn 2, Issue 1, 2000, Pages 4-14

  Sorajja, P ^a   Elliott, P M ^a   McKenna, W J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Genetics; Hypertrophic cardiomyopathy; Sudden death

Indexed keywords

CARDIAC MYOSIN; CARRIER PROTEIN; MYOSIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; MYOSIN IIB; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN 2; MYOSIN LIGHT CHAIN I; MYOSIN-BINDING PROTEIN C; NONMUSCLE MYOSIN TYPE IIB HEAVY CHAIN; TROPOMYOSIN; TROPONIN; TROPONIN I; TROPONIN T;

ANIMAL; GENETIC MARKER; GENETICS; GENOTYPE; HEART MUSCLE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; METABOLISM; METHODOLOGY; MOLECULAR BIOLOGY; MORTALITY; MUTATION; PROGNOSIS; REVIEW; SUDDEN DEATH;

ANIMALS; CARDIAC MYOSINS; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; DEATH, SUDDEN, CARDIAC; GENETIC MARKERS; GENOTYPE; HUMANS; MOLECULAR BIOLOGY; MUTATION; MYOCARDIUM; MYOSIN HEAVY CHAINS; MYOSIN LIGHT CHAINS; MYOSINS; NONMUSCLE MYOSIN TYPE IIB; PROGNOSIS; TROPOMYOSIN; TROPONIN; TROPONIN I; TROPONIN T;

EID: 0033754705     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.1999.0067     Document Type: Article

References (63)

1. Maron BJ, Bonow RO, Cannon RO III. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 316:1987;780-789.
2. Maron BJ, Shirani J, Poliac LC. Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA. 276:1996;199-204.
3. Spirito P, Seidman CE, McKenna WJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 336:1997;775-785.
4. Mogensen J, Klausen IC, Pedersen AK. α-Cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest. 103:1999;R39-R43.
5. Poetter K, Jiang H, Hassanzadeh S. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscles. Nature Genet. 13:1996;63-69.
6. Kimura A, Harada H, Park J-E. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nature Genet. 16:1997;379-382.
7. MacRae CA, Ghaisas N, Kass S. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest. 96:1995;1216-1220.
8. Rayment I, Rypniewski WR, Schmidt-Bäse K. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science. 261:1993;50-56.
9. Carrier L, Bonne G, Bahrend E. Organization and sequence of human cardiac myosin binding protein C gene (MyBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res. 80:1997;427-434.
10. Gautel M, Suffardi O, Freiburg A. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? EMBO J. 14:1995;1952-1960.
11. Bejsovec A, Anderson P. Myosin heavy-chain mutations that disrupt caeonorhabditis elegans thick filament assembly. Genes Dev. 2:1988;1307-1317.
12. Lankford EB, Epstein ND, Fananapazir L. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest. 95:1995;1409-1414.
13. Sweeney HL, Straceski AJ, Leinwand LA. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem. 269:1994;1603-1605.
14. Cuda G, Fananapazir L, Zhu W. Skeletal muscle expression and abnormal function of β-myosin in hypertrophic cardiomyopathy. J Clin Invest. 91:1993;2861-2865.
15. Watkins H, Seidman CE, Seidman JG. Expression and functional assessement of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. J Clin Invest. 98:1996;2456-2461.
16. Straceski AJ, Geisterfer-Lowrance AAT, Seidman CE. Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A. 91:1994;589-593.
17. Marian AJ, Yu Q-T, Mann D. Expression of the mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. Circ Res. 77:1995;98-106.
18. Geisterfer-Lowrance AAT, Christe M, Conner DA. A mouse model for familial hypertrophic cardiomyopathy. Science. 272:1996;731-734.
19. Berul CI, Christe M, Aronovitz MJ. Electrophysiological abnormalities and arrhythmias in α-MHC mutant familial hypertrophic cardiomyopathy mice. J Clin Invest. 99:1997;570-576.
20. Vikstrom KL, Factor SM, Leinwand LA. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med. 2:1996;556-567.
21. Tardiff JC, Factor SM, Tompkins BD. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Invest. 101:1998;2800-2811.
22. Beall C, Sepanski MA, Fyrberg EA. Genetic dissection of Drosophila myofibril formation; effects of actin and myosin heavy chain null alleles. Genes Deve. 3:1989;131-140.
23. Fyrberg E, Fyberg CC, Beall C. Drosophila melanogaster troponin-T mutations engender three distinct syndromes of myofibrillar abnormalities. J Mol Biol. 216:1990;657-675.
24. Jones WK, Grupp IL, Doetschman T. Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest. 98:1996;1906-1917.
25. Marian AJ, Zhao G, Seta Y, Roberts R, Yu Q-T. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. Circ Res. 81:1997;76-85.
26. Fujita H, Sugura S, Momomura S. Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants: molecular force level of mutant myosins may have a prognostic implication. J Clin Invest. 99:1997;1010-1015.
27. Lin D, Bobkova A, Homsher E. Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. J Clin Invest. 97:1996;2842-2848.
28. Bottinelli R, Coviello DA, Redwood CS. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ Res. 82:1998;106-115.
29. 2+regulation of thin filament motiity. Biochem Biophys Res Commun. 236:1997;760-764.
30. 2+-sensitizing effects of the mutations at lle-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy. Am J Physiol. 275:1998;C200-7.
31. Osterop AP, Kofflard MJ, Sandjuijl LA. AT1 Receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension. 32:1998;825-830.
32. Brugada R, Kelsey W, Lechin M. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Invest Med. 45:1997;542-551.
33. Marian AJ, Yu Q-T, Workman R. Angiotensin converting enzyme polymorphism is associated with hypertrophic cardiomyopathy as well as sudden cardiac death. Lancet. 342:1993;1073-1074.
34. Lechin M, Quiñones M, Omran A. Angiotensin-I converting enzyme genotypes influence the phenotypic expression of hypertrophic cardiomyopathy. Circulation. 92:1995;1808-1812.
35. Geisterfer-Lowrance AAT, Kass S, Tanigawa G. A molecular basis for familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 77:1994;701-712.
36. Watkins H, McKenna WJ, Thierfelder L. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 332:1995;1058-1064.
37. Watkins H, Rosenzweig A, Hwang DS. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Eng J Med. 326:1992;1108-1114.
38. Epstein ND, Cohn GM, Cyran F. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the β-myosin heavy chain gene. Circulation. 86:1992;345-352.
39. Marian AJ, Mares A, Kelly DP. Sudden cardiac death in hypertrophic cardiomyopathy: variability in phenotypic expression of β-myosin heavy chain mutations. Eur Heart J. 16:1995;368-376.
40. Conte MR, Morello M, Mangiardi L. An ARG403GLN β-myosin heavy chain gene mutation identified in an Italian family with hypertrophic cardiomyopathy: description of clinical features of the family members. Eur Heart J. 18:1997;1033-1037.
41. Anan R, Greve G, Thierfelder L. Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest. 93:1994;280-285.
42. Marian AJ, Roberts R. Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death. J Cardiovasc Electrophysiol. 9:1998;88-99.
43. Spirito P, Chiarella F, Carratino L. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 320:1989;749-755.
44. Fananazapir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation. 89:1994;22-32.
45. Abchee A, Marian AJ. Prognostic significance of β-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy. J Invest Med. 45:1997;191-196.
46. Posen BM, Moolman JC, Corfield VA. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac β myosin heavy chain gene mutations. Br Heart J. 74:1995;40-46.
47. Dausse E, Komajda M, Fetler L. Familial hypertrophic cardiomyopathy: microsatellite haplotyping and identification of a hot spot for mutations in the β-myosin heavy chain gene. J Clin Invest. 92:1993;2807-2813.
48. Charron P, Dubourg O, Desnos M. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy: a comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur Heart J. 19:1998;139-145.
49. Thierfelder L, Watkins H, MacRae C. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 77:1994;701-712.
50. Moolman JC, Corfield VA, Posen B. Sudden death due to troponin T mutations. J Am Coll Cardiol. 29:199;549-555.
51. Nakajima-Taniguchi C, Matsui H, Fujio Y. Novel missense mutation in cardiac troponin T gene found in a Japanese patient with hypertrophic cardiomyopathy. J Mol Cell Cardiol. 29:1997;839-843.
52. Forissier J-F, Carrier L, Farza H. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation. 94:1996;3069-3073.
53. Anan R, Shono H, Kisanuki A. Patients with familial hypertrophic cardiomyopathy caused by a Phe 110lle missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis. Circulation. 98:1998;391-397.
54. Carrier L, Hengstenberg C, Beckmann JS. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nature Genet. 4:1993;311-313.
55. Bonne G, Carrier L, Bercovici J. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature Genet. 11:1995;438-440.
56. Watkins H, Conner D, Thierfelder L. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genet. 11:1995;434-437.
57. Nimura H, Bachinski LL, Sangwatanaroj S. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 338:1998;1248-1257.
58. Charron P, Dubourg O, Desnos M. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation. 97:1998;2230-2236.
59. Thierfelder L, MacRae C, Watkins H. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci U S A. 90:1993;6270-6274.
60. Yamauchi-Takihara K, Nakajima-Taniguchi C, Matsui H. Clinical implications of hypertrophic cardiomyopathy associated with mutations in the α-tropomyosin gene. Heart. 76:1996;63-65.
61. Coviello DA, Maron BJ, Spirito P. Clinical features of hypertophic cardiomyopathy caused by mutation of a 'hot spot' in the alpha-tropomyosin gene. J Am Coll Cardiol. 29:1997;635-640.
62. Flavigny J, Richard P, Isnard R. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. J Mol Med. 76:1998;208-214.
63. Seidman CE, Seidman JG. Gene mutations that cause familial hypertrophic cardiomyopathy. Haber E. Molecular cardiovascular medicine. 1995;193-209 Scientific American, New York.